These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6613236)

  • 1. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
    Schulz W; Wendt T; Scherer D; Kober G
    Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine.
    Schulz W; Kober G; Bernauer R; Kaltenbach M
    Am Heart J; 1985 Mar; 109(3 Pt 2):694-9. PubMed ID: 3838406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1.
    Sobolski J; Vandermoten P; Stoupel E; Berkenboom G; Degre S
    Am Heart J; 1985 Mar; 109(3 Pt 2):700-3. PubMed ID: 3838407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and passive coronary vasodilation after intracoronary and sublingual nitroglycerin.
    Schulz W; von Anderten W; Reiber JH; Bernauer R; Kaltenbach M; Kober G
    Z Kardiol; 1983; 72 Suppl 3():82-6. PubMed ID: 6421018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of intracoronary injection of SIN-1 on vasoconstriction of epicardial arteries induced by acetylcholine].
    Dubois-Randé JL; Adnot S; Dupouy P; Castaigne A; Geschwind H
    Arch Mal Coeur Vaiss; 1993 Jun; 86(6):881-7. PubMed ID: 8274060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.
    Serruys PW; Deckers JW; Luijten HE; Reiber JH; Tijssen JG; Chadha D; Hugenholtz PG
    Eur Heart J; 1987 Mar; 8(3):263-70. PubMed ID: 3582385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific coronary hemodynamic effects of nisoldipine and other vasoactive drugs.
    Vrolix M; Piessens J
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S43-9. PubMed ID: 1282613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteries.
    Dubois-Rande JL; Dupouy P; Geschwind H; Castaigne A; Adnot S
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):462-7. PubMed ID: 7504139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
    Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
    J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].
    Münzel T; Kurz S; Heitzer T; Luhmann C; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():38-41. PubMed ID: 7968900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute and chronic effects of molsidomine in therapeutic coronary angioplasty].
    Darius H; Erbel R; Rupprecht HJ; Pop T; Meyer J
    Med Klin (Munich); 1990 Feb; 85 Suppl 1():23-6. PubMed ID: 2185404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic response to intracoronary injection of a vasodilator during coronary angiography. A randomized comparative study of trinitrin and linsidomin ].
    Chevalier B; Lancelin B
    Arch Mal Coeur Vaiss; 1991 Sep; 84(9):1345-51. PubMed ID: 1958119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SIN-1 in intracoronary administration].
    Schulz W
    Presse Med; 1988 May; 17(20):1027-32. PubMed ID: 2969098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent vasodilatation in human epicardial coronary arteries: effect of prolonged exposure to glyceryl trinitrate or SIN-1.
    Kuhn M; Förstermann U
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S47-54. PubMed ID: 2484699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in human coronary flow reserve after administration of intracoronary diltiazem.
    Vrolix MC; Sionis D; Piessens J; Van Lierde J; Willems JL; De Geest H
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S64-7. PubMed ID: 1725547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ischemic actions of molsidomine by venous and large coronary dilatation in combination with antiplatelet effects.
    Bassenge E; Mülsch A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S23-8. PubMed ID: 2484695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of patients with coronary heart disease using isosorbide dinitrate, nifedipine and molsidomine.
    Jansen W; Tauchert M; Osterspey A; Hombach V; Fuchs M; Hilger HH
    Z Kardiol; 1983; 72 Suppl 3():203-10. PubMed ID: 6689389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.